A federal judge citing the Purvi Patel case as part of his crusade to declare mifepristone unsafe and remove it from the market nationally is alarming.
APR 26, 2023
JESSICA MASON PIEKLO, Rewire News
The Supreme Court granted a reprieve in the far-right’s fight to upend medication abortion access—for now.
The Court on Friday stayed the order U.S. District Judge Matthew Kacsmaryk had issued earlier in the month from Amarillo, Texas that purported to pull FDA approval of mifepristone, one of two drugs used in medication abortions. By putting a hold on Kacsmaryk’s lawless order, the Court has maintained the status quo regarding mifepristone access. That means it will be months, if not longer, before anti-abortion advocates will be able to weaponize the courts in their bid to restrict, if not remove entirely, access to the drug.